Esplanade Ventures
Esplanade Ventures is a Canadian digital health venture capital firm that leads and co-leads Seed to Series A investments in AI-enabled digital health companies commercializing in North America, offering portfolio support alongside capital.
- Company typePrivate
- Founded2019
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Esplanade Ventures does
Esplanade Ventures is a Toronto-based venture capital firm founded in 2019 by Dr. Sheldon Elman and Stuart M. Elman, focused exclusively on early-stage digital health companies commercializing in North America. The firm invests at the Seed and Series A stages with selective Series B and follow-on participation, and explicitly prefers AI-enabled software that directly impacts patients or healthcare professionals while excluding invasive devices and biotech. The portfolio of 22 companies spans oncology care navigation (Cerula Care), AI medical interpretation (No Barrier), radiology AI (Rad AI), neurology (Neura Health), and other digital health verticals. Notable portfolio exits include Brainbox and Carebook.
The firm's core offering combines venture capital with active portfolio support. Beyond capital, Esplanade provides hands-on guidance, commercial introductions, and go-to-market strategy to portfolio companies, leveraging a network across payer, provider, employer, and technology ecosystems spanning North America, Europe, and Israel. The team of approximately nine members blends operators (Dr. Sheldon Elman, founder of Medisys Health Group), investors (Stuart M. Elman, co-founder of Persistence Capital Partners), and clinical or policy advisors including former Health Canada Deputy Minister Simon Kennedy and Harvard-trained emergency physician Dr. Yosef Berlyand.
Esplanade operates as a private Canadian limited partnership generating revenue through standard venture capital economics: management fees on committed fund capital and carried interest on investment gains. Distribution occurs exclusively through direct investment relationships with founders, supported by deal sourcing across the firm's healthcare network and event presence. The firm maintains offices in Toronto (headquarters) and Montreal (Westmount), and does not publicly disclose fund size, AUM, or revenue figures.
Esplanade Ventures firmographics
Firmographics- Name
- Esplanade Ventures
- Legal name
- Esplanade Ventures
- Website
- https://esplanadeventures.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Esplanade Ventures is a Canadian digital health venture capital firm that leads and co-leads Seed to Series A investments in AI-enabled digital health companies commercializing in North America, offering portfolio support alongside capital.
- Ownership category
- akta.pro rank
Esplanade Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Finance and Insurance (52)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industries
- Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA), Healthcare Access & Life Sciences Impact Funds (FSANAJAI), Impact / ESG Venture Capital (FSANAAAG)
Keywords
Where Esplanade Ventures is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Esplanade Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Investment Returns and Management Fees: As a venture capital firm, Esplanade Ventures generates returns through successful exits of portfolio companies, carried interest on investment gains, and management fees from fund operations. They invest early in digital health companies and support their growth through active partnership until exit.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Esplanade Ventures product offering
Product offeringCore offering
Esplanade Ventures provides early-stage venture capital funding (Seed to Series A, with selective Series B) to digital health companies commercializing in North America, with a preference for AI-enabled software solutions. Beyond capital, the firm bundles hands-on portfolio support including commercial introductions, GTM strategy guidance, and direct access across payer, provider, employer, and technology ecosystems spanning North America, Europe, and Israel.
Product overview
Esplanade Ventures is a Canadian digital health venture capital firm offering a unified investment and advisory service rather than a traditional product platform. The core offering combines venture capital funding (Seed to Series A rounds, with selective Series B and follow-on investments) with hands-on portfolio support including hands-on guidance, commercial introductions, and GTM strategy. The firm's distinguishing value lies in its network access across payer, provider, employer, and technology ecosystems spanning North America, Europe, and Israel. There are no separate product modules; the investment and support services function as an integrated service offering for digital health startups.
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital Investment Services Early-stage venture capital funding from Seed to Series A rounds (with selective Series B and follow-on investment) directed at digital health companies commercializing in North America, with a preference for AI-enabled software solutions impacting patients or healthcare professionals. The firm leads, co-leads, and follows investments.
Quantifiable outcome
- 22 companies backed in portfolio
Companies that use Esplanade Ventures
Customer profileSegments1 record
Ideal customer profiles1 record
Esplanade Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Esplanade Ventures partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Esplanade Ventures competitors and assessment
Company assessmentDirect peers
- Rock Health Capital: US-based seed and early-stage digital health venture fund; the most direct competitor. Esplanade has even co-invested alongside Rock Health Capital in No Barrier, evidencing direct overlap in deal sourcing and stage focus.
- Flare Capital Partners: Boston-based early-stage digital health VC investing at Seed and Series A in companies transforming healthcare delivery, with strong provider and payer network — closely comparable thesis, stage, and value-add model.
- Venrock: Long-standing US venture firm with a healthcare practice investing at Seed through Series A in digital health companies; similar stage and operator-led positioning.
- iGan Partners: Toronto-based early-stage medical device and digital health VC; cited in team background of Esplanade's Principal Alexandre Nossovskoi, indicating direct overlap in Canadian digital health sourcing.
- Maverick Ventures: Early-stage health and technology VC fund with focus on Seed and Series A digital health companies; comparable stage and operator-led model with overlapping target founders.
Broad incumbents
- Andreessen Horowitz (a16z Bio/Health): Major US venture firm with a dedicated bio/health fund investing across digital health and healthtech stages. Competes for the same AI-enabled digital health deals but with materially larger fund size and broader portfolio.
- General Catalyst (Health & Wellness): Multi-stage venture firm with a dedicated health practice actively leading Series A and B in digital health and AI health startups; broader portfolio and capital base overlap with Esplanade's later-stage opportunities.
- Optum Ventures: Strategic venture arm of Optum (UnitedHealth Group) actively investing in early-stage digital health and AI health startups with deep payer-provider access; broader corporate mandate but overlapping target companies.
Regional players
- Creative Destruction Lab (CDL): Toronto-based seed-stage accelerator with a health stream; former affiliation of Esplanade's Principal. Operates as a non-equity/equity-light program targeting similar early-stage digital health founders in Canada.
- TELUS Ventures: Strategic venture arm of TELUS (which acquired Medisys Health Group, founded by Esplanade's co-founder) investing in digital health and healthtech; relevant as a Canadian strategic investor in the same thesis area.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Esplanade Ventures social profiles
Digital presenceEsplanade Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Esplanade Ventures leadership team
Management profileNumber of profiles
Profiles9 records
Esplanade Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Esplanade Ventures M&A and investment
M&A and investmentM&A
Investments16 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Esplanade Ventures
What does Esplanade Ventures do?
Esplanade Ventures provides early-stage venture capital funding (Seed to Series A, with selective Series B) to digital health companies commercializing in North America, with a preference for AI-enabled software solutions. Beyond capital, the firm bundles hands-on portfolio support including commercial introductions, GTM strategy guidance, and direct access across payer, provider, employer, and technology ecosystems spanning North America, Europe, and Israel.
Is Esplanade Ventures a public or private company?
Esplanade Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Esplanade Ventures founded?
Esplanade Ventures was founded in 2019. It employs 1 to 10 people.
Where is Esplanade Ventures based?
Esplanade Ventures is headquartered in Toronto, Canada, in the North America region.
How does Esplanade Ventures make money?
One revenue line is on record: investment Returns and Management Fees.
Who are Esplanade Ventures's main competitors?
Direct peers on record are Rock Health Capital, Flare Capital Partners, Venrock, iGan Partners and Maverick Ventures. Broad incumbents are Andreessen Horowitz (a16z Bio/Health), General Catalyst (Health & Wellness) and Optum Ventures. Regional players are Creative Destruction Lab (CDL) and TELUS Ventures.
Does Esplanade Ventures have an API?
No public API is recorded for Esplanade Ventures.
What industry is Esplanade Ventures in?
Esplanade Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed). Its NAICS code is 523940 and its SIC code is 6282.